WuXi Biologics, a leading global Contract Research, Development and Manufacturing Organization (CRDMO), and Toregem BioPharma, a biotech startup company from Kyoto University, announced that...
WuXi Biologics ("WuXi Bio") , a global CRDMO service company, announced it has successfully launched the GMP operation of its new drug product facility...
WuXi Biologics, a global Contract Research, Development and Manufacturing Organization (CRDMO) service company, announced that the company received the award for Bioprocessing Excellence in...
WuXi Biologics ("WuXi Bio") (2269.HK), a global company with leading open-access biologics technology platforms, announced that it has completed a remote GMP inspection by...
WuXi Biologics, a global company with leading open-access biologics technology platforms, and ImmuneOncia Therapeutics, Inc., a clinical-stage, immuno-oncology company in South Korea, announced that...
